Effects of oestrogens on thyroxine turnover in hyperthyroidism.
D000328:Adult; D004967:Estrogens / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006111:Graves Disease / Q000188:drug therapy; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy* / Q000378:metabolism; D007275:Injections, Intravenous; D007456:Iodine Isotopes; D008297:Male; D008713:Methimazole / Q000008:administration & dosage / Q000494:pharmacology; D008875:Middle Aged; D010636:Phenols / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D010919:Placebos; D013961:Thyroid Gland / Q000378:metabolism; D013974:Thyroxine / Q000097:blood / Q000378:metabolism*; D013975:Thyroxine-Binding Proteins
D004967:Estrogens; D007456:Iodine Isotopes; D010636:Phenols; D010919:Placebos; D013975:Thyroxine-Binding Proteins; D008713:Methimazole; D010672:Phenytoin; D013974:Thyroxine